Luveltamab tazevibulin,Pegfilgrastim
Sutro Biopharma,Amgen
['stro,002,gm1', 'gyn', 'ovarian', 'stro-002-gm1']
ana oaknin: luveltamab tazevibulin (stro-002), an anti-folate receptor alpha (folr ) antibody drug conjugate (adc), safety &amp; efficacy in a broad distribution of folr exp in pts w/ recurrent ovarian cancer (oc): update of stro-002-gm1 p 1 dose expansion cohort. #asco23 #gyncsm 
18-year Ovarian Cancer Survivor/Research Advocate. 2 recurrences, now 15 years NED. Loves laughter theater puzzles F1 & PoGO. Evidence based medicine=HOPE